introduction: non-alcoholic fatty liver disease (nafld) has become the most common cause of liver disease worldwide. it has been suggested that dietary composition plays a role in nafld pathogenesis; thus, changing dietary patterns may constitute a therapeutic resource even in the absence of weight reduction. the aim of this study was to identify the characteristic of suitable dietary pattern i...

Introduction: Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of liver disease worldwide. It has been suggested that dietary composition plays a role in NAFLD pathogenesis; thus, changing dietary patterns may constitute a therapeutic resource even in the absence of weight reduction. The aim of this study was to identify the characteristic of suitable dietary pattern i...

aim : the aim of this study was to review cases of non-alcoholic fatty liver disease (nafld) cases and to determine the prevalence of non-alcoholic fatty liver disease as a cause of elevated alanine aminotransferase (alt) in healthy blood donors in the permian area and also assess risk factors of nafld such as body mass index (bmi) and correlation with metabolic syndrome in these subjects. back...

nonalcoholic fatty liver disease (nafld) is one of the aspects of metabolic syndrome (mets). due to the increase of mets in iran, this study was conducted to determine the prevalence of nafld, its potential predictors and their sex distribution in north of iran, amol.in 2008 this population based cross-sectional study included 5023 adult individuals who were randomly selected from amol healthca...

Background: Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) is a common public health problem. Visfatin is secreted by visceral adipose tissue and is an adipocytokine. It could be a pro-inflammatory adipocytokine and is related to the metabolic syndrome and non-alcoholic fatty liver disease. This study evaluated the association between visfatin levels in patients w...

â  â  no treatment has been proven to be effective in nonalcoholic fatty liver disease (nafld) and/or steatohepatitis (nash). numerous studies have addressed this issue. however conclusive recommenâ­dations cannot be drawn solely from the currently available studies. hence we performed this systematic review to determine which of the available therapeutic modalities are supported by adequate ev...

context non-alcoholic fatty liver disease (nafld) is a chronic liver disease, with 5-10% of liver having extra fat. increase in its prevalence in all age groups is linked with obesity and type ii diabetes. the treatment of nafld remains controversial. a growing body of evidence suggests a relation between overgrowth of gut microbiota with nafld and non-alcoholic steatohepatitis (nash). the obje...

in the present study, we examined the relationship between family history of cardiovascular diseases (cvd), dyslipidemia, hypertension, and diabetes with laboratorial abnormalities and syndromes in iranian patients with non-alcoholic fatty liver disease (nafld). a total of 332 nafld patients from our outpatient clinic were consecutively entered into analysis. exclusion criteria were having diab...